366 related articles for article (PubMed ID: 33573665)
1. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Ferrannini G; De Bacquer D; Vynckier P; De Backer G; Gyberg V; Kotseva K; Mellbin L; Norhammar A; Tuomilehto J; Wood D; Rydén L;
Cardiovasc Diabetol; 2021 Feb; 20(1):38. PubMed ID: 33573665
[TBL] [Abstract][Full Text] [Related]
2. Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V.
Ferrannini G; De Bacquer D; De Backer G; Kotseva K; Mellbin L; Wood D; Rydén L;
Diabetes Care; 2020 Apr; 43(4):726-733. PubMed ID: 32079627
[TBL] [Abstract][Full Text] [Related]
3. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
[TBL] [Abstract][Full Text] [Related]
4. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.
Anand SS; Dagenais GR; Mohan V; Diaz R; Probstfield J; Freeman R; Shaw J; Lanas F; Avezum A; Budaj A; Jung H; Desai D; Bosch J; Yusuf S; Gerstein HC;
Eur J Prev Cardiol; 2012 Aug; 19(4):755-64. PubMed ID: 21551215
[TBL] [Abstract][Full Text] [Related]
5. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.
Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T
BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743
[TBL] [Abstract][Full Text] [Related]
6. Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.
Smaradottir MI; Ritsinger V; Gyberg V; Norhammar A; Näsman P; Mellbin LG
Diab Vasc Dis Res; 2017 Mar; 14(2):69-76. PubMed ID: 28118730
[TBL] [Abstract][Full Text] [Related]
7. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
Hage C; Lundman P; Rydén L; Mellbin L
Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design.
Mohammedi K; Préaubert N; Cariou T; Rigalleau V; Foussard N; Piazza L; Bairras-Martin C; Couffinhal T; Bezin J; Benard A
Cardiovasc Diabetol; 2021 Mar; 20(1):63. PubMed ID: 33714278
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia.
Kuhl J; Jörneskog G; Wemminger M; Bengtsson M; Lundman P; Kalani M
Cardiovasc Diabetol; 2015 Sep; 14():120. PubMed ID: 26382578
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?
Ferrannini G; Svenungsson E; Kjellström B; Elvin K; Grosso G; Näsman P; Rydén L; Norhammar A
Diab Vasc Dis Res; 2020; 17(3):1479164120922123. PubMed ID: 32506943
[TBL] [Abstract][Full Text] [Related]
11. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
[TBL] [Abstract][Full Text] [Related]
12. Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.
Ferrannini G; De Bacquer D; Gyberg V; De Backer G; Kotseva K; Mellbin LG; Risebrink R; Tuomilehto J; Wood D; Rydén L
Diabetes Res Clin Pract; 2022 Jan; 183():109156. PubMed ID: 34843858
[TBL] [Abstract][Full Text] [Related]
13. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.
Kotseva K; De Backer G; De Bacquer D; Rydén L; Hoes A; Grobbee D; Maggioni A; Marques-Vidal P; Jennings C; Abreu A; Aguiar C; Badariene J; Bruthans J; Castro Conde A; Cifkova R; Crowley J; Davletov K; Deckers J; De Smedt D; De Sutter J; Dilic M; Dolzhenko M; Dzerve V; Erglis A; Fras Z; Gaita D; Gotcheva N; Heuschmann P; Hasan-Ali H; Jankowski P; Lalic N; Lehto S; Lovic D; Mancas S; Mellbin L; Milicic D; Mirrakhimov E; Oganov R; Pogosova N; Reiner Z; Stöerk S; Tokgözoğlu L; Tsioufis C; Vulic D; Wood D;
Eur J Prev Cardiol; 2019 May; 26(8):824-835. PubMed ID: 30739508
[TBL] [Abstract][Full Text] [Related]
14. Prediabetes and Risk for Cardiac Death Among Patients With Coronary Artery Disease: The ARTEMIS Study.
Kiviniemi AM; Lepojärvi ES; Tulppo MP; Piira OP; Kenttä TV; Perkiömäki JS; Ukkola OH; Myerburg RJ; Junttila MJ; Huikuri HV
Diabetes Care; 2019 Jul; 42(7):1319-1325. PubMed ID: 31076416
[TBL] [Abstract][Full Text] [Related]
15. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes.
Wallander M; Söderberg S; Norhammar A
Diabet Med; 2008 Aug; 25(8):949-55. PubMed ID: 18959608
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
[TBL] [Abstract][Full Text] [Related]
17. Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men.
Otsuka F; Sugiyama S; Kojima S; Maruyoshi H; Funahashi T; Sakamoto T; Yoshimura M; Kimura K; Umemura S; Ogawa H
Circ J; 2007 Nov; 71(11):1703-9. PubMed ID: 17965488
[TBL] [Abstract][Full Text] [Related]
18. Impaired glucose tolerance and future cardiovascular risk after coronary revascularization: a 10-year follow-up report.
Tsuchida K; Mitsuma W; Sato Y; Ozaki K; Soda S; Hatada K; Tanaka K; Hosaka Y; Imai S; Takahashi K; Matsubara T; Oda H
Acta Diabetol; 2020 Feb; 57(2):173-182. PubMed ID: 31375898
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Persistent Impaired Glucose Tolerance in Patients with Minor Ischemic Stroke or Transient Ischemic Attack.
Osei E; den Hertog HM; Fonville S; Brouwers PJAM; Mulder LJMM; Koudstaal PJ; Dippel DWJ; Zandbergen AAM; Lingsma HF
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104815. PubMed ID: 32303400
[TBL] [Abstract][Full Text] [Related]
20. Plasma BNP Levels and Diuretics Use as Predictors of Cardiovascular Events in Patients with Myocardial Infarction and Impaired Glucose Tolerance.
Shindo K; Fukuda H; Hitsumoto T; Ito S; Kim J; Washio T; Kitakaze M
Cardiovasc Drugs Ther; 2020 Feb; 34(1):79-88. PubMed ID: 32076931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
